2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy

D. Shprecher, J. Hentz, C. Adler, B. Dugger, H. Shill, E. Driver-Dunkley, S. Mehta, M. Sabbagh, C. Belden, R. Savica, L. Sue, T. Beach (Sun City, AZ, USA)

Clinical Phenomenology and Rating Scales

12:00pm-1:30pm

Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease

S.J. Kim, E.J. Chung (Busan, Korea)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Verbal fluency deficits in essential tremor patients: Underlying structural changes

E.A. Pelzer, C. Nelles, D.J. Pedrosa, L. Burghaus, C. Eggers, C. Melzer, M. Tittgemeyer, L. Timmermann (Cologne, Germany)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial

J.L. Purks, A. Zeymo, N.M. Shara, K.E. Anderson, I. Shoulson (Washington, DC, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

A. Shalash, D. Hassan (Cairo, Egypt)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2